Implications of findings in the coronary drug project for secondary prevention trials in coronary heart disease. The coronary; drug project research group.

P L Canner, M Halperin

Registry-linked trialAbstract readClinical Trial

In one paragraph

Trial report in Circulation, 1981. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT00000482. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed, 1 pooled it

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00000482 phase3completed

Coronary Drug Project

Ran1965Registered outcomes0Posted comparisons0ConditionsCardiovascular Diseases, Coronary Disease, Heart Diseases, Myocardial InfarctionArmsclofibrate clofibrate, dextrothyroxine sodium, Estrogen, niacin

PMID 4275188 PMID 4320008 PMID 4337170 PMID 4356847 PMID 4570454 PMID 457827 PMID 4610000 PMID 6501718 PMID 6999345 PMID 7002353 PMID 7094247 PMID 7261627other papers from this trial

Open the trial in the graph

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS).The American journal of cardiology · 2009 · on this map
Pooled it

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

P L Canner

M Halperin

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultBlood PressureCholesterolClinical Trials as TopicCoronary DiseaseHumansMaleMiddle AgedMyocardial InfarctionPlacebosRiskSmokingCholesterolPlacebos

Identifiers

PMID7014029

DOI10.1161/01.cir.63.6.1342

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

NCT00000482ClinicalTrials.gov

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.